Ozempic 00169-1302
Generic: Semaglutide
Product NDC
00169-1302- Manufacturer
- Novo Nordisk Pharmaceutical Industries, Lp
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 7, 2022
- Listing Expires
- December 31, 2027
- Application
- NDA209637
Need to source Ozempic? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Semaglutide | .25 mg/.5mL |
Drug Class
GLP-1 Receptor Agonist [EPC]GLP-1 Receptor Agonist [EPC]Glucagon-Like Peptide 1 [CS]